Health Condition 1: R098- Other specified symptoms and signsinvolving the circulatory and respiratory systems
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients Age greater than or equal to 18 years 2. Patients Admitted to General Wards, IMCU B,under hospital monitored home care,or transported via hospital ambulance services, 3. Patients Expected to remain under hospital supervision for more than 24 hours 4. Patients who are able and willing to provide consent
Exclusion criteria
Exclusion criteria: Participants will be excluded if they: 1. Are directly admitted to ICU at the time of patch placement 2. Are designated as terminally ill directive 3. Are under end-of-life care support 4. Have known persistent arrhythmias, pacemakers, or ECG interference (e.g., excessive motion artifacts) 5. Decline or are unable to provide informed consent 6. Have incomplete medical records or leave against medical advice during patch monitoring 7. Post cardiac transplant patients
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Lead Time (Threshold Alert) 2. Time to Treatment 3. RRT Activation Rate 4. Code Blue Incidence 5. Unplanned ICU Transfers 6. In-Hospital Mortality 7. Hospital Length of Stay Timepoint: 1. Daily,2. Daily, 3.7days,4weeks,8weeks, 4.7days,4weeks,8weeks 5.7days,4weeks,8weeks 6. At Discharge or 8 weeks 7. At Discharge | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Alert Frequency per Patient 2. False Alert Rate 3. Clinical Concordance 4. Lead Time Advantage vs NEWS2 5. Early Intervention Incidence 6. Cross-setting Feasibility 7. Staff Usability Feedback 8. System Specific Alert Classification 9.Diagnosis Associated with Alert 10. Alert-to Intervention Correlation 11. Spot Check Verification Rate 12. Spot Check Concordance 13. False Alert Identification via Spot Check 14. NEWS2 vs Dashboard EWS Monitoring Concordance 15. Device Signal Uptime 16. ECG Deterioration Events 17. Retrospective Trend Analysis Utility Timepoint: Daily & cumulative at Week 4 & Week 8 for outcomes 1 5, 8, 9, 10 16. Outcome 6 at 8 weeks. Outcome 7 at Week 4 & 8. Outcome 17 at discharge & cumulative at Week 8. | — |
Countries
India
Contacts
PSG Institute of Medical Sciences and Research